Seminal works have discovered that BM-MSCs have the intriguing potential to induce skeletal muscle regeneration in the mdx mouse, a model for DMD, in which mutations in exon 23 of the dystrophin gene lead to the protein deletion, thus mimicking the human pathology characterized by progressive muscle degeneration. Here, DMD is linked to Duchenne muscular dystrophy.